Topic Hub
4 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 4 of 4 clinical reviews.
A detailed examination of enrollment biases, follow-up gaps, generalizability concerns, statistical caveats, and conflict-of-interest disclosures in the STEP-TEENS semaglutide trial for adolescent obesity.
Read clinical reviewHealth-economic analysis of semaglutide 2.4 mg in adolescents from the STEP-TEENS trial: cost per QALY, payer coverage barriers, list-price vs net-price gaps, and value calculations for families weighing treatment initiation.
Read clinical reviewA detailed plain-English breakdown of the STEP-TEENS trial, which tested semaglutide 2.4 mg in adolescents with obesity and found 16.1% weight loss versus 0.6% with placebo.
Read clinical reviewA deep-dive into how the STEP-TEENS trial reshaped adolescent obesity treatment guidelines, prescribing patterns, and real-world clinical decision-making for semaglutide 2.4 mg in teenagers.
Read clinical review